Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy

Journal of Endocrinological Investigation

Volumn 19, Issue 2, 1996, Pages 127-130

  Conti, A ^a,b   Sartorio, A ^a,b   Ferrero, S ^a,b   Ferrario, S ^c   Ambrosi, B ^b  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Ospedale Caduti Bollatesi   (Italy)

Author keywords

Autoimmune disorders; Bone Gla protein; Collagen; Steroids treatment; Telopeptide

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN TYPE 1; CORTICOSTEROID; GLUCOCORTICOID; OSTEOCALCIN; PREDNISONE; PROCOLLAGEN;

ADULT; ARTICLE; AUTOIMMUNITY; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG THERAPY; FEMALE; HUMAN; MALE; MIXED CONNECTIVE TISSUE DISEASE; ORAL DRUG ADMINISTRATION; OSSIFICATION; OSTEOLYSIS; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029979574     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349848     Document Type: Article

References (26)

1. Reid I.R. Pathogenesis and treatment of steroid osteoporosis. Clin. Endocrinol. (Oxf.) 30: 89, 1989.
2. Lukert B.P., Raisz L.G. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann. Intern. Med. 112: 352, 1990.
3. Orth D.N., Kovacs W.J., Debold C.R. The adrenal cortex. In: Wilson J.B., Foster D.W. (Eds.), Williams Textbook of Endocrinology, ed. 8. Saunders W.B. Co. Philadelphia, 1992, p. 489.
4. Greenberger P.A., Hendrix R.W., Patterson R., Chmiel J.S. Bone studies in patients on prolonged systemic corticosteroid therapy for asthma. Clin. Allergy 12: 363, 1982.
5. Dempster D.W., Arlott M.A., Meunier P.J. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid induced osteoporosis. Calcif. Tissue Int. 35: 410, 1983.
6. Reid I.R., King A.R., Alexander C.J., Ibbertson H.K. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-biphosphonate (APD). Lancet 1: 143, 1988.
7. Cutroneo K.R., Rokowski R., Counts D.F. Glucocorticoids and collagen synthesis: comparison of in vivo and cell culture studies. Collagen Rel. Res. 1: 557, 1981.
8. Sartorio A., Conti A., De Giuseppe A., Ambrosi B., Faglia G. Livelli sierici di osteocalcina e propeptide aminoterminale del procollagene III in pazienti con sindrome di Cushing prima e dopo intervento chirurgico. In: Pietri P. (Ed.), "XI Congresso Nazionale S.I.E.C. Milano, 6-9 novembre 1991". Monduzzi Editore, 1991, p. 515.
9. Piovesan A., Terzolo M., Reimondo G., Pia A., Codegone A., Osella G., Boccuzzi A., Paccotti P., Angeli A. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. Horm. Metab. Res. 26: 234, 1994.
10. Epstein S. Serum and urinary markers of bone remodeling: assessment of bone turnover. Endocr. Rev. 9: 437, 1988.
11. Price P.A., Parthemore J.C., Deftos L.J. New biochemical marker for bone metabolism. Clin. Invest. 66: 878, 1988.
12. Delmas P.D. Biochemical markers of bone metabolism. Presse Med. 22: 263, 1993.
13. Eriksen E.F., Charles P., Melsen F., Mosekilde L., Risteli L., Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease. Correlation with bone histomorphometry. Bone Min. Res. 8: 127, 1993.
14. Sartorio A., Ambrosi B., Colombo P., Morabito F., Faglia G. Osteocalcin levels in Cushing's disease before and after treatment. Horm. Metab. Res. 20: 70, 1988.
15. Sartorio A., Monzani M., Conti A., Casati G., Faglia G. Serum aminoterminal propeptide of type IM procollagen (PIIINP) levels in patients with acromegaly before and after pituitary adenomectomy. Eur. J. Intern. Med. 4: 79, 1993.
16. Sartorio A., Conti A., Monzani M. New markers of bone and collagen turnover in children and adults with growth hormone deficiency. Postgrad. Med. J. 69: 846, 1993.
17. Gevers G., Devos P., De Roo M., Dequeker J. Increased levels of osteocalcin (bone gla protein) in rheumatoid arthritis. Br. J. Rheumatol. 28: 207, 1989.
18. Marhoffer W., Schatz H., Stranke H., Ullmann J., Schmidt K., Federlin K. Serum osteocalcin levels in rheumatoid arthritis: a marker of accelerated bone turnover in late onset rheumatoid arthritis. Rheumatol. 18: 1158, 1991.
19. Als O.S., Riis B.J., Gotfredsen A., Christiansen C., Deftos L.J. Biochemical markers of bone turnover in rheumatoid arthritis. Acta Med. Scand. 219: 209, 1986.
20. Kröger H., Risteli J., Risteli L., Penttilä I., Alhava E. Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis. Ann. Rheum. Dis. 52: 338, 1993.
21. Weisman M.H., Orth R.W., Catherwood B.D., Manolagas S.C., Deftos L.J. Measures of bone loss in rheumatoid arthritis. Arch. Intern. Med. 146: 701, 1986.
22. Montecucco C., Baldi F., Fortina A., Tomassinin G., Caporali R., Cherie-Ligniere E.L., Fratino P. Serum osteocalcin (bone Gla-protein) following corticosteroid therapy in postmenopausal women with rheumatoid arthritis. Comparison of the effect of prednisone and deflazacort. Clin. Rheumatol. 7: 366, 1988
23. Gennari C., Imbimbo B., Montagnani M., Bernini M., Nardi P., Avioli L.V. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif. Tissue Int. 36: 245, 1984.
24. Ali N.J., Capewell S., Ward M.J. Bone turnover during high dose inhaled corticosteroid treatment. Thorax 46: 160, 1991.
25. Sartorio A., Conti A., Ferrario S., Passini E., Re T., Ambrosi B. Serum bone Gla-protein (BGP) and carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in patients with Cushing's syndrome before and after surgery. Postgrad. Med. J. 1996 (in press).
26. Oikarinen A., Autio P., Vuori J., Vaananen K., Ristel L., Kiistala U., Risteli J. Systemic glucocorticoid treatment decreases serum concentrations of carboxytelminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen. Br. J. Dermatol. 126: 172, 1992.